Koo

You are correct. If Resverlogix continued on their current path of development it would be an infinite time for payback. If however a purchaser who had the financial juice to pay a fare price for RVX in the first place came along then I could see that development path dramatically reduced. I think it was 4 or 5 AGM's ago that it was stated that of the 86 major diseases that we as humans most often encounter that RVX had identified 42 diseases that their technologies would have a positive affect on. I don't believe it would take to long before an acquiring company would exploit the opportunities that they had acquired.

tada